Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
מצבים רפואיים
Diabetic Nephropathies · Kidney Failure, Chronic · Diabetes Mellitus Type 1 · Heart Failure
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Stanford University Medical Center, Stanford, California, United States
Contact: Principal Investigator (Marina Basina, MD)David Maahs, MD (Sub-investigator)Barbara Davis Center / University of Colorado Denver, Aurora, Colorado, United States
Contact: Principal Investigator (Sarit Polsky, MD)Halis Akturk, MD (Sub-investigator)AdventHealth, Orlando, Florida, United States
Contact: Principal Investigator (Tina Thethi)Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
Contact: Principal Investigator (Amisha Wallia, MD)Joslin Diabetes Center, Boston, Massachusetts, United States
Contact: Study coordinator (Christine Mendonca) · christine.mendonca@joslin.harvard.edu · 617-334-2257Contact: Principal Investigator (Alessandro Doria, MD PhD MPH)Elena Toschi, MD (Sub-investigator)Sylvia Rosas, MD (Sub-investigator)Washington University, St Louis, Missouri, United States
Contact: Principal Investigator (Janet McGill, MD)Kai Jones, MD (Sub-investigator)Maamoun Salam, MD (Sub-investigator)Huda Al-Bahadili, MD (Sub-investigator)SUNY Upstate Medical University, Syracuse, New York, United States
Contact: Principal Investigator (Ruth Weinstock, MD)Malek El Muayed, MD, MSCI (Sub-investigator)Katherine McPhee, MSN, FNP-C, RN (Sub-investigator)Albert Einstein College of Medicine / Montefiore Medical Center, The Bronx, New York, United States
Contact: Principal Investigator (Matthew Abramowitz, MD)Jill Crandall, MD (Sub-investigator)Justin Mathew, MD (Sub-investigator)Cleveland Clinic Foundation, Cleveland, Ohio, United States
Contact: Principal Investigator (Luiza Caramori, MD PhD)Keren Zhou, MD (Sub-investigator)Oregon Health and Science University, Portland, Oregon, United States
Contact: Principal Investigator (Rodica Busui, MD, PhD)Andrew Ahmann, MD (Sub-investigator)University of Texas Southwestern, Dallas, Texas, United States
Contact: Principal Investigator (Ildiko Lingvay, MD)Amy Shah, MD (Sub-investigator)Oksana Hamidi, DO (Sub-investigator)University of Washington, Seattle, Washington, United States
Contact: Principal Investigator (Petter Bjornstad, MD)Irl Hirsch, MD (Sub-investigator)Ian de Boer, MD (Sub-investigator)Kalie Tommerdahl, MD (Sub-investigator)Providence Sacred Heart Medical Center, Spokane, Washington, United States
Contact: Principal Investigator (Katherine R. Tuttle, MD)Radica Alicic, MD (Sub-investigator)Michael Ryan, MD (Sub-investigator)Unversity of Calgary, Calgary, Alberta, Canada
Contact: Principal Investigator (Ronald Sigal, MD MPH)Alberta Diabetes Institute, Edmonton, Alberta, Canada
Contact: Principal Investigator (Peter Senior, MD)Anna Lam, MD (Sub-investigator)St. Paul's Hospital, Vancouver, British Columbia, Canada
Contact: Principal Investigator (Adeera Levin, MD)Sean Barbour, MD (Sub-investigator)LMC Diabetes and Endocrinology, Toronto, Ontario, Canada
Contact: Principal Investigator (Ronnie Aronson, MD)Toronto General Hospital, Toronto, Ontario, Canada
Contact: Principal Investigator (David Cherney, MD)Bruce Perkins, MD MPH (Sub-investigator)Vikas S. Sridhar, MD (Sub-investigator)Ayodele Odutayo, MD (Sub-investigator)Huajing Ni, MD (Sub-investigator)Taewon Yi, MD (Sub-investigator)Institut de Recherches Cliniques de Montréal, Montreal, Quebec, Canada
Contact: Principal Investigator (Remi Rabasa-Lhoret, MD)Nadine Taleb, MD (Sub-investigator)
מובילי המחקר
Alessandro Doria, MD PhD MPH
Principal Investigator
Joslin Diabetes Center
Michael Mauer, MD
Principal Investigator
University of Minnesota
David Cherney, MD PhD
Principal Investigator
University of Toronto